These data suggest a potential role for dysregulated FOXO3 expression in ACD/MPV, which may contribute to decreased endothelial cell proliferation resulting in reduced capillary density in the lungs of patients with ACD/MPV. Here, FOXO3 is linked to granular corneal dystrophy type II.